[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BRPI0513856A - uso de um composto peptìdico - Google Patents

uso de um composto peptìdico

Info

Publication number
BRPI0513856A
BRPI0513856A BRPI0513856-6A BRPI0513856A BRPI0513856A BR PI0513856 A BRPI0513856 A BR PI0513856A BR PI0513856 A BRPI0513856 A BR PI0513856A BR PI0513856 A BRPI0513856 A BR PI0513856A
Authority
BR
Brazil
Prior art keywords
compounds
peptide compound
toxins
peptide
bacterial
Prior art date
Application number
BRPI0513856-6A
Other languages
English (en)
Inventor
Johannes Jakobus Grote
Jan Wouter Drijhout
Pieter Sicco Hiemstra
Maartje Johanna Nell
Marcel Jan Vonk
Guido Vicent Bloemberg
Original Assignee
Octoplus Sciences Bv
Academisch Ziekenhuis Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octoplus Sciences Bv, Academisch Ziekenhuis Leiden filed Critical Octoplus Sciences Bv
Publication of BRPI0513856A publication Critical patent/BRPI0513856A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

USO DE UM COMPOSTO PEPTìDICO A presente invenção diz respeito a um grupo de compostos peptídicos que têm atividade antimicrobiana. Os compostos também têm afinidade para toxinas e especialmente para toxinas bacterianas, tais como lipopolissacarídeo ou ácido lipoteicóico. Os compostos podem ser usados para fabricar medicamentos úteis para o tratamento de infecções bacterianas ou fúngicas. Os medicamentos podem ser administrados sistêmica ou localmente.
BRPI0513856-6A 2004-07-28 2005-07-26 uso de um composto peptìdico BRPI0513856A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04077175A EP1621205A1 (en) 2004-07-28 2004-07-28 Antimicrobial peptides derived from CAP18
PCT/NL2005/000545 WO2006011792A2 (en) 2004-07-28 2005-07-26 Antimicrobial peptides derived from cap18

Publications (1)

Publication Number Publication Date
BRPI0513856A true BRPI0513856A (pt) 2008-05-20

Family

ID=34928414

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513856-6A BRPI0513856A (pt) 2004-07-28 2005-07-26 uso de um composto peptìdico

Country Status (11)

Country Link
US (2) US7803756B2 (pt)
EP (3) EP1621205A1 (pt)
JP (1) JP2008508265A (pt)
KR (1) KR20070050941A (pt)
CN (1) CN101018563A (pt)
AU (1) AU2005267651B2 (pt)
BR (1) BRPI0513856A (pt)
CA (1) CA2574959A1 (pt)
NZ (1) NZ553175A (pt)
RU (1) RU2392962C2 (pt)
WO (1) WO2006011792A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1621205A1 (en) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18
AU2007329708B2 (en) 2006-12-01 2012-08-02 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
CA2694440A1 (en) 2007-07-25 2009-01-29 Biolex Therapeutics, Inc. Controlled release interferon drug products and treatment of hcv infection using same
CN102405053B (zh) 2009-01-06 2015-07-29 C3剑股份有限公司 靶向抗微生物部分
EP2488210A4 (en) 2009-10-12 2014-04-30 Smith Holdings Llc METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING IN VITO OR IN VITRO-ADMINISTERED OLIGONUCLEOTIDE MEDICAMENTS
RU2434880C1 (ru) * 2010-07-21 2011-11-27 Общество С Ограниченной Ответственностью "Биохарт" Полипептид, имеющий антибактериальную активность и пригодный для получения лекарственных средств для лечения бактериальных инфекций человека
JP6348901B2 (ja) * 2012-05-09 2018-06-27 コントラフェクト コーポレイション バクテリオファージ溶解素によるバイオフィルムの防止、破壊および処置
DK2994154T3 (da) 2013-05-10 2020-04-20 Academisch Ziekenhuis Leiden Antimikrobielt peptid
US9387189B2 (en) 2013-05-22 2016-07-12 Professional Compounding Centers Of America (Pcca) Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
WO2015075406A1 (en) * 2013-11-19 2015-05-28 Lipopeptide Ab New treatment of chronic ulcers
TR201815301T4 (tr) 2013-12-12 2018-11-21 Acad Medisch Ct Antimikrobiyal peptit ve bunun kullanımları.
WO2015164289A1 (en) * 2014-04-21 2015-10-29 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
AU2022350478A1 (en) * 2021-09-21 2024-04-11 Biomedit, Llc Antimicrobial peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4037525B2 (ja) * 1998-03-25 2008-01-23 生化学工業株式会社 新規抗菌性ペプチド
DE602004021901D1 (de) * 2003-01-28 2009-08-20 Academisch Ziekenhuis Leiden Aus ll-37 abgeleiteten peptidinhibitoren von toxinen
WO2005040192A2 (en) * 2003-10-21 2005-05-06 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
EP1621205A1 (en) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18

Also Published As

Publication number Publication date
RU2392962C2 (ru) 2010-06-27
AU2005267651B2 (en) 2010-05-27
CN101018563A (zh) 2007-08-15
US7803756B2 (en) 2010-09-28
RU2007107390A (ru) 2008-09-10
WO2006011792A3 (en) 2006-09-14
CA2574959A1 (en) 2006-02-02
WO2006011792A2 (en) 2006-02-02
US20110053835A1 (en) 2011-03-03
EP1784206A2 (en) 2007-05-16
JP2008508265A (ja) 2008-03-21
NZ553175A (en) 2009-10-30
EP1621205A1 (en) 2006-02-01
KR20070050941A (ko) 2007-05-16
AU2005267651A1 (en) 2006-02-02
EP2221061A1 (en) 2010-08-25
US20080249022A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
BRPI0513856A (pt) uso de um composto peptìdico
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BRPI0810064B8 (pt) compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos
BRPI0414581C1 (pt) composto, composição farmacêutica compreendendo o referido composto e uso do referido composto
MY150958A (en) Compounds for the treatment of multi-drug resistant bacterial infections
BRPI0411016A (pt) composições antisépticas, processos e sistemas
BRPI0612125A2 (pt) compostos da fórmula (i), processo para a fabricação destes, composto da fórmula iiia, composições farmacêuticas, método para o tratamento e/ou profilaxia de doenças associadas à modulação dos receptores cb1 e uso de compostos
EA200970081A1 (ru) Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения
BRPI0714803B8 (pt) compostos peptidomiméticos de smac, seus usos, e composição farmacêutica
BRPI0821110B8 (pt) anticorpo de neutralização de anti-nr10/il31ra, composição farmacêutica compreendendo o referido anticorpo e uso do mesmo
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
NZ597046A (en) Use of alpha-toxin for treating and preventing staphylococcus infections
BRPI0412291A (pt) antagonistas duplos de nka/nk3 para o tratamento de esquizofrenia
NO20076675L (no) Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet
CL2004000930A1 (es) Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos.
ECSP045353A (es) Derivados de benzoxazinona, su preparación y aplicación como medicamentos
BRPI0507801A (pt) compostos de azetidina substituìda, processo para a preparação de compostos de azetidina substituìda, medicamento e uso de pelo menos um composto de azetidina substituìda
RU2012157473A (ru) Способ выявления или лечения реакции "трансплантат против хозяина"
BRPI0516077A (pt) composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes
WO2007132314A3 (en) Substituted piperidino phenyloxazolidinones
BR0309757A (pt) 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases
UY28542A1 (es) Amidas macrocíclicas antibacterianas
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
BRPI0612534B8 (pt) uso de um composto derivado de quinolina, o referido composto, sua combinação, composição farmacêutica, uso da referida combinação, e produto
BRPI0514892A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2316 DE 26-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.